The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMRYT PHARMA PLC SPONSORED ADS 03217L106   15,322,649 2,098,993 SH   SOLE   2,098,993 0 0
ARGENX SE SPONSORED ADR 04016X101   9,091,920 24,000 SH   SOLE   24,000 0 0
ARROWHEAD PHARMACEUTICALS IN COM 04280A100   44,758,568 1,103,515 SH   SOLE   1,103,515 0 0
ARVINAS INC COM 04335A105   23,055,522 673,941 SH   SOLE   673,941 0 0
BLUEPRINT MEDICINES CORP COM 09627Y109   25,487,256 581,768 SH   SOLE   581,768 0 0
GENMAB A/S SPONSORED ADS 372303206   10,291,898 242,848 SH   SOLE   242,848 0 0
KYMERA THERAPEUTICS INC COM 501575104   15,710,099 629,411 SH   SOLE   629,411 0 0
MERUS N V COM N5749R100   22,154,726 1,432,109 SH   SOLE   1,432,109 0 0
PIERIS PHARMACEUTICALS INC COM 720795103   4,734,991 4,552,876 SH   SOLE   4,552,876 0 0
REGENXBIO INC COM 75901B107   20,359,473 897,684 SH   SOLE   897,684 0 0
SILENCE THERAPEUTICS PLC ADS 82686Q101   19,583,028 1,284,133 SH   SOLE   1,284,133 0 0
S&P BIOTECH ETF TR UNIT 78464A870   41,500,000 500,000 SH Put SOLE   0 0 500,000
UNIQURE NV SHS N90064101   14,165,440 624,854 SH   SOLE   624,854 0 0